clinical trial diversity

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Featured in Pharmaceutical Outsourcing, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations (CROs), …

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials Read More »

Enhancing Patient Access and Retention in Rare Disease Clinical Trials

Enhancing Patient Access and Retention in Rare Disease Clinical Trials

Featured in an article in PM360, Scott Gray, CEO, discusses new developments in the rare disease clinical trial industry ahead of the upcoming Rare Disease Day on February 28, 2022. Learn more about alleviating financial barriers to trial participation, mitigating geographical barriers to trial participation, and the federal efforts to support rare disease trials in …

Enhancing Patient Access and Retention in Rare Disease Clinical Trials Read More »

Medicaid clinical trials routine costs

Medicaid Coverage of “Routine Costs” for Clinical Trials

Featured in Applied Clinical Trials, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations …

Medicaid Coverage of “Routine Costs” for Clinical Trials Read More »

Practical Approach to Clinical Trial Diversity

A Practical Approach to Clinical Trial Diversity

In an article featured in BioProcess International, Scott Gray, CEO, discusses a practical approach to achieving inclusive representation in clinical studies. Life-science companies can attract large, diverse participant pools by reaching patients where they live, providing targeted and meaningful messaging about the benefits of trials and offering ongoing assistance.

rare disease trials patient support services

BioProcess International eBook: Patient Support for Rare Disease Trials

Download the eBook today! By providing direct support to participants from enrollment through the end of a clinical trial, logistics-management companies can help ease the financial, logistical, and psychological barriers to patient participation in rare disease trials. Such dedicated services can build trust between participants or caregivers and patient coordinators, improving the overall trial experience …

BioProcess International eBook: Patient Support for Rare Disease Trials Read More »

CISCRP patient diversity inclusion equity

CISCRP: Supporting Patient Diversity Campaign

Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.